SHEZF Stock Price, Chart, Stats & News
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHEZF) is a dividend-paying stock with a current dividend yield of 9.03% as of Aug 13, 2026. It pays $0.0424 per share over the trailing twelve months. Its dividend has grown at a 12.43% 5-year compound annual rate.
Dividend safety
SHEZF pays out about 110% of earnings, leaving little safety margin.
SHEZF chart
About
Shenzhen Hepalink Pharmaceutical Group Co., Ltd., established in 1998 and headquartered in Shenzhen, People's Republic of China, operates as a global pharmaceutical enterprise. Having adopted its current name in February 2017 (formerly Shenzhen Hepalink Pharmaceutical Co.,Ltd.), the company specializes in the production and worldwide distribution of pharmaceutical products across diverse markets including Hong Kong, the United States, Europe, and mainland China. Its comprehensive business operations are structured into four key divisions: finished dose pharmaceutical products, active pharmaceutical ingredients (APIs), contract development and manufacturing organization (CDMO) services, and an 'other' category.
Related lists
Similar securities
Based on sector and market capitalization
